Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) Profit After Tax (2018 - 2025)

Historic Profit After Tax for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$7.4 million.

  • Q32 Bio's Profit After Tax rose 5800.51% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.1 million, marking a year-over-year increase of 3054.4%. This contributed to the annual value of -$47.7 million for FY2024, which is 1118.29% up from last year.
  • According to the latest figures from Q3 2025, Q32 Bio's Profit After Tax is -$7.4 million, which was up 5800.51% from -$9.5 million recorded in Q2 2025.
  • Over the past 5 years, Q32 Bio's Profit After Tax peaked at $92.1 million during Q1 2022, and registered a low of -$34.3 million during Q4 2022.
  • Its 5-year average for Profit After Tax is -$12.1 million, with a median of -$14.2 million in 2024.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 868387.7% in 2022, then tumbled by 117201.17% in 2025.
  • Q32 Bio's Profit After Tax (Quarter) stood at -$33.6 million in 2021, then decreased by 2.12% to -$34.3 million in 2022, then rose by 21.08% to -$27.1 million in 2023, then skyrocketed by 47.58% to -$14.2 million in 2024, then skyrocketed by 47.92% to -$7.4 million in 2025.
  • Its Profit After Tax stands at -$7.4 million for Q3 2025, versus -$9.5 million for Q2 2025 and -$11.0 million for Q1 2025.